Mary Ann E. Zagaria, PharmD, MS, CGP
Senior Care Consultant Pharmacist
President, MZ Associates, Inc.
Robert R. Muder, MD
Professor of Medicine
University of Pittsburgh School of Medicine
Chief, Infectious Disease Section
VA Pittsburgh Healthcare System
Pharmacists: 1.25 Contact Hours (0.125 CEUs)
NOTE: This activity was presented on November 10, 2010, in conjunction with ASCP's Annual Meeting and Exhibition.
Participants who received credit for attending either the live presentation or the webcast on that date are not eligible to receive credit for this online activity.
Older adults face an increased risk of infection, bacteremia, and mortality caused by Streptococcus pneumoniae. To prevent invasive pneumococcal disease (IPD) in the elderly population, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommends vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV) for all persons aged 65 years or older. In February 2010, the Trust for America's Health, the Infectious Diseases Society of America, and the Robert Wood Johnson Foundation released a report showing that 33.1% of adults ages 65 and older had not been immunized against pneumonia in 36 states as of 2008. This falls short of the Healthy People 2010 project goal of achieving vaccination rates of 90% among persons age 65 and older. Poor vaccination rates have serious consequences: in 2006, there were approximately 41,000 cases of IPD in the U.S., resulting in 5,000 deaths.
Consultant pharmacists are poised to take a leadership role in improving pneumococcal vaccination rates among older adults, including those in LTC settings. This activity will provide information to improve knowledge about pneumococcal vaccination and detail strategies to overcome common impediments to vaccination, such as patient apprehension and institutional barriers. Target Audience
This educational activity is designed to meet the needs of consultant and senior care pharmacists.
Upon completion of this knowledge-based educational activity, the participant should be able to:
Describe the safety risks of PPV and how these compare to the risks of developing IPD among older adults who remain unvaccinated.
Summarize the clinical data surrounding pneumococcal revaccination in older adults.
Implement guideline-recommended algorithms for the administration of second PPV doses in elderly patients who require revaccination.
List strategies to overcome institutional barriers to pneumococcal vaccination in the LTC setting, including the use of standing orders and vaccination protocols.
In accordance with the standards set forth by the Accreditation Council for Pharmacy Education, it is the policy of the American Society of Consultant Pharmacists to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker¹s interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Dr. Zagaria has no relevant financial relationships with any commercial interests to disclose.
Dr. Muder has no relevant financial relationships with any commercial interests to disclose.
This educational activity may contain discussion of published and/or investigational uses of pharmaceutical agents. Some uses of these agents may not have been approved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Credit Statements
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity, ACPE Universal Activity #203-999-10-111-H01-P, has been assigned 1.25 Contact Hours (0.125 CEUs).
Participants must view the activity in its entirety, successfully complete the post-test, and submit an evaluation to receive continuing pharmacy education credit. Credit will be awarded for a score of 70% or better, and a statement may be printed immediately after passing the post-test.
Partial credit cannot be awarded.
There is no fee to participate in this educational activity.
Commercial Support Statements
This activity is supported through an educational grant from Pfizer Inc.
Minimum System Requirements:
• Pentium III, 600 MHz or Equivalent Processor
• 512 MB of RAM
• Windows XP, Vista, or 7. Or, Mac OS X
• 800x600 Monitor Resolution
• 16-bit Color
• 16 bit Sound Card with Speakers
Please turn off all pop-up blockers to assure access to the educational activity.
Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
The activity will take approximately 60 minutes to complete.
After the activity has finished, click on the "Post-test" button.
Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen. A credit statement/certificate will be awarded for a score of 70% or better and may be printed immediately after passing the post-test.